Miami Center for AIDS Research
迈阿密艾滋病研究中心
基本信息
- 批准号:10458278
- 负责人:
- 金额:$ 195.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-11-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS related cancerAIDS/HIV problemAcademyAchievementAcquired Immunodeficiency SyndromeAdministrative SupplementAdvisory CommitteesAffectAfrican American populationAgingAreaAwardCancer CenterCareer MobilityChildClinicalClinical SciencesCohort StudiesCollaborationsCommunicable DiseasesCommunitiesCommunity OutreachCountyDevelopmentDoctor of PhilosophyEducationElementsEmerging Communicable DiseasesEpidemicEventFacultyFaculty RecruitmentFederally Qualified Health CenterFloridaFosteringFundingGeographyGoalsGrantGrowthHIVHealthHealth PolicyHospitalsImmune responseImmunotherapyIndividualIndustryInfectionInflammationInfrastructureInjecting drug userInstitutesInstitutionInterest GroupInternationalKnowledgeLaboratoriesLatinoLatinxLeadershipLesbian Gay Bisexual Transgender QueerLifeLinkMalignant NeoplasmsMental HealthMentorsMentorshipMetabolismMinorityMissionNational Institute of Mental HealthNeedle-Exchange ProgramsNeeds AssessmentNeurosciencesPersonsPlayPositioning AttributeResearchResearch PersonnelResource AllocationResourcesRoleScienceShapesStrategic PlanningThe Multicenter AIDS Cohort StudyTranslational ResearchTreatment outcomeUnited States National Institutes of HealthUniversitiesWomanWomen&aposs Interagency HIV Studyacronymsbasebehavioral/social sciencebiobehaviorcareer developmentcommunity engagementexperiencehealth equityimprovedinnovationmedical schoolsmen who have sex with menmental health centernext generationnovelperinatal HIVpre-exposure prophylaxispreventprogramsrecruitreproductive outcomesuccesssynergismtooltransmission processworking group
项目摘要
Project Summary/Abstract (Overall)
The Miami Center for AIDS Research (CFAR) at the University of Miami (UM) Miller School of Medicine (MSOM)
is the only CFAR in Florida, the state with the highest rate of new infections with Miami as its epicenter,
underscoring the need for a CFAR. In the past 5 years, the Miami CFAR has catalyzed innovative research in
health equity and ending the HIV epidemic (EHE), HIV in women, AIDS related malignancies, HIV cure, and
immune responses and has increased the Funded Research Base. It has developed a new Mentoring Academy
program to launch junior investigators into leadership positions and added 14 new faculty. It has supported nearly
$3 million in pilot awards between CFAR (1.45 million) and State ($1.6 million), and received >$1.6 million in NIH
Administrative Supplements. During the proposed 4th cycle of funding, notable new successes at UM have
propelled the CFAR’s ability to leverage new resources. These achievements include the Center for HIV and
Research in Mental Health (CHARM), awarded by NIMH in 2019, Sylvester Cancer Center (SCC), that received
NCI Cancer Center designation also in 2019; and the Clinical and Translational Science Institute (CTSI) that was
renewed in 2018. The Miami CFAR’s five Cores, Administrative, Developmental, Clinical Sciences, Laboratory
Sciences, Bio-Behavioral and Community Engagement, and the HIV & Aging Scientific Working Group (SWG)
collaborate on the following 5 specific aims of the CFAR to promote the CFAR mission. Aim 1: Provide scientific
leadership dedicated to support HIV/AIDS research to define scientific priorities, in alignment with the NIH,
institutional and geographic needs; Aim 2: Leverage Institutional resources and enhance relationships with the
afore-mentioned new Centers and HEIDI (HIV/AIDS and Emerging Infectious Diseases Institute), supported by
the State, and UM Departments; Aim 3: Catalyze the synergies between Miami CFAR Cores, SWG, Scientific
Interest Groups (SIGs) to collaborate with national research networks, industry, other FL institutions, and other
CFARs; Aim 4: Grow the next generation of leaders in HIV/AIDS research through mentoring, career
development and funding support; Aim 5: Nurture the partnership with the Florida Department of Health for
research implementation, increase the reach of the CFAR towards EHE, and promote community outreach
events to build on Miami CFAR’s efforts for community engagement. Under the leadership of Savita Pahwa, MD,
Director and Mario Stevenson, PhD, Co-Director, the Miami CFAR has established an enviable position at the
MSOM with HIV/AIDS research being designated as one of four strategic pillars that have been prioritized for
resource allocation and faculty recruitment. The Internal and External Advisory Committees, and strategic
planning provide opportunities for appraisal to improve the CFAR. With its strong infrastructure, capable faculty,
strong collaborative interactions within and outside of UM, and opportunities for leveraging UM and State
resources, we are confident that the next cycle of the Miami CFAR will be successful in achieving its goals.
项目摘要/摘要(总体)
迈阿密艾滋病研究中心(CFAR)迈阿密大学(UM)米勒医学院(MSOM)
是佛罗里达州唯一的CFAR,该州的新感染率最高,迈阿密是其震中,
强调对CFAR的需求。在过去的5年中,迈阿密CFAR催化了创新研究
卫生公平和结束艾滋病毒流行(EHE),妇女的艾滋病毒,与艾滋病相关的疟疾,艾滋病毒治愈和
免疫反应并增加了资助的研究基础。它已经建立了新的指导学院
计划启动初级调查人员的领导职位,并增加了14个新教师。它几乎支持
CFAR(145万)与州(160万美元)之间的300万美元试点奖,并获得了160万美元的NIH
行政补品。在拟议的第四个资金周期中,UM的显着新成功
推动了CFAR利用新资源的能力。这些成就包括艾滋病毒中心和
NIMH于2019年,Sylvester Cancer Center(SCC)授予的心理健康研究(CHARM),收到了
NCI癌症中心的名称也在2019年;以及临床和转化科学研究所(CTSI)
2018年更新。迈阿密CFAR的五个核心,行政,发展,临床科学,实验室
科学,生物行为和社区参与,以及艾滋病毒和老化科学工作组(SWG)
CFAR的以下5个具体目标以促进CFAR任务进行合作。目标1:提供科学
专门支持艾滋病毒/艾滋病研究的领导者,以与NIH保持一致,定义科学重点
机构和地理需求;目标2:利用机构资源并增强与
关于新中心和海蒂(艾滋病毒/艾滋病和新兴的传染病研究所),由
国家和UM部门;目标3:催化迈阿密CFAR核心,SWG,科学的协同作用
利益集团(SIGS)与国家研究网络,行业,其他FL机构以及其他
cfars;目标4:通过心理,职业发展艾滋病毒/艾滋病研究的下一代领导者
发展和资金支持;目标5:培养与佛罗里达卫生部的合作伙伴关系
研究实施,增加CFAR对EHE的影响力,并促进社区外展
旨在以迈阿密CFAR为社区参与的努力为基础的活动。在马里兰州萨维塔·帕瓦(Savita Pahwa)的领导下
迈阿密CFAR的主任和马里奥·史蒂文森(Mario Stevenson)博士在
MSOM与艾滋病毒/艾滋病研究被指定为已被优先考虑的四个战略支柱之一
资源分配和教师招聘。内部和外部咨询委员会以及战略
计划为评估提供了改善CFAR的机会。具有强大的基础设施,有能力的教师,
UM内外的强大协作互动,以及利用UM和州的机会
资源,我们相信迈阿密CFAR的下一个周期将成功实现其目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Savita Pahwa其他文献
Savita Pahwa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Savita Pahwa', 18)}}的其他基金
Immune Dysfunction in HIV+ Opioid Users
HIV 阿片类药物使用者的免疫功能障碍
- 批准号:
10343782 - 财政年份:2020
- 资助金额:
$ 195.54万 - 项目类别:
Immune Dysfunction in HIV+ Opioid Users
HIV 阿片类药物使用者的免疫功能障碍
- 批准号:
10001242 - 财政年份:2020
- 资助金额:
$ 195.54万 - 项目类别:
Immune correlates of LTBI in HIV-exposed infants
HIV 暴露婴儿 LTBI 的免疫相关性
- 批准号:
10543401 - 财政年份:2019
- 资助金额:
$ 195.54万 - 项目类别:
Immunity and HIV persistence in perinatal HIV infection
围产期 HIV 感染中的免疫和 HIV 持续性
- 批准号:
9211649 - 财政年份:2016
- 资助金额:
$ 195.54万 - 项目类别:
Immunity and HIV persistence in perinatal HIV infection
围产期 HIV 感染中的免疫和 HIV 持续性
- 批准号:
9302666 - 财政年份:2016
- 资助金额:
$ 195.54万 - 项目类别:
Antibody Responses in Aging SIV Infected Monkeys
感染 SIV 的衰老猴子的抗体反应
- 批准号:
9120783 - 财政年份:2015
- 资助金额:
$ 195.54万 - 项目类别:
Immune Activation in Virologically Suppressed Indian HIV-infected Patients
病毒学受到抑制的印度艾滋病毒感染者的免疫激活
- 批准号:
8540075 - 财政年份:2013
- 资助金额:
$ 195.54万 - 项目类别:
相似海外基金
Children's National Hospital Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
国家儿童医院基地联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599559 - 财政年份:2022
- 资助金额:
$ 195.54万 - 项目类别:
A technology-based psychosocial intervention to support social engagement and well-being in adults aging with HIV
基于技术的社会心理干预,支持艾滋病毒感染者的社会参与和福祉
- 批准号:
10481052 - 财政年份:2022
- 资助金额:
$ 195.54万 - 项目类别:
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
HIV基因驱动疗法:针对高危人群的单次给药干预
- 批准号:
10404422 - 财政年份:2021
- 资助金额:
$ 195.54万 - 项目类别:
Adolescent health at the intersections of sexual, gender, racial/ethnic, immigrant identities and native language: a supplementary study of HIV/AIDS preventive behaviors
性、性别、种族/族裔、移民身份和母语交叉点的青少年健康:艾滋病毒/艾滋病预防行为的补充研究
- 批准号:
10450345 - 财政年份:2021
- 资助金额:
$ 195.54万 - 项目类别:
A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups
HIV基因驱动疗法:针对高危人群的单次给药干预
- 批准号:
10597282 - 财政年份:2020
- 资助金额:
$ 195.54万 - 项目类别: